Purpose: Elevated donor-derived cell-free DNA (dd-cfDNA) has been observed in transplant patients undergoing acute rejection, but the relationship between dd-cfDNA and long term outcomes has not previously been studied. In… Click to show full abstract
Purpose: Elevated donor-derived cell-free DNA (dd-cfDNA) has been observed in transplant patients undergoing acute rejection, but the relationship between dd-cfDNA and long term outcomes has not previously been studied. In this exploratory study, serially measured dd.cfDNA from heart transplant patients is used for predict 3-year patient adverse outcomes of death, retransplantation, hemodynamic compromise or graft dysfunction.
               
Click one of the above tabs to view related content.